Specialists for Fabry disease

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Kate Hanneman
Rare Disease Specialist
University Health Network
Toronto, Ontario
QC-verified 22
Wei-Li Chen, M.D
Rare Disease / Clinical Research
NTUH
WASHINGTON, DC
QC-verified PI×2 593
Caroline Kistorp, Professor
Rare Disease Specialist
Rigshospitalet
Copenhagen
QC-verified
Roman Günthner, PD Dr.
Rare Disease Specialist
Abteilung für Nephrologie
München, Bavaria
QC-verified PI×1
Eva Brand, MD, PhD
Rare Disease Specialist
Fabry disease center Berlin - Charité - Universitätsmedizin Berlin
Berlin
QC-verified
Charles Jia-Yin Hou
Rare Disease Specialist
Charles Jia-Yin Hou
Taipei
QC-verified 36
Caroline M Kistorp, MD, Ph.D
Rare Disease Specialist
Rigshospitalet
Copenhagen
QC-verified
Jianhua Mao, PhD
Rare Disease Specialist
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality
PI×3
eleonora riccio, md
Rare Disease / Clinical Research
Federico II University
PI×2
Antonio Pisani, MD, PhD
Rare Disease / Clinical Research
Università degli Studi di Napoli "Federico II" NAPOLI
ROCHESTER, NY
PI×2 1
Albert HAGEGE, Dr
Rare Disease Specialist
20 Rue Leblanc, HEGP/PARCC, 75015 Paris
Paris, Paris
Jeanine R. Jarnes, PharmD
Rare Disease / Clinical Research
University of Minnesota - Fairview
MINNEAPOLIS, MN
PI×3
Ozlem Goker-Alpan, MD
Rare Disease Specialist
Lysosomal & Rare Disorders Research & Treatment Center, Inc.
Fairfax, Virginia
PI×9
Erica Daina, MD
Rare Disease / Clinical Research
Mario Negri Institute for Phrmacological Research
PI×2
Caroline M Kistorp, Professor
Rare Disease Specialist
Centre for Cancer and Organ Disease, Department for Medical Endocrinology, Rigshospitalet
Copenhagen
PI×2
Alan H Cohen, MD
Rare Disease / Clinical Research
4D Molecular Therapeutics
PI×2
Peter Nordbeck, MD, PhD
Rare Disease / Clinical Research
Wuerzburg University Hospital
PI×2
Arian Pano, MD, MPH
Rare Disease Specialist
The Kirklin Clinic Of university of Alabama Birmingham Hospital
Birmingham, Alabama
Wladimir MAUHIN, Doctor
Rare Disease Specialist
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, France
PI×2
Zhihong Liu, MD
Rare Disease / Clinical Research
Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine
PI×8
Elena Biagini, MD, PhD
Rare Disease Specialist
IRCCS Azienda Ospedaliero-Universitaria
Chieti, Abruzzo/Chieti
PI×2
David G Warnock, MD, MD
Rare Disease / Clinical Research
University of Alabama at Birmingham
BIRMINGHAM, AL
PI×2
Arndt Rolfs, Prof. Dr.
Rare Disease / Clinical Research
CENTOGENE GmbH Rostock
PI×4
SANDRINE LEMOINE, PU-PH
Rare Disease Specialist
Hopital Edouard Herriot
Lyon, France
Oliver Price, PhD
Rare Disease Specialist
University of Leeds
Leeds, Leeds
Maria Blomqvist, Ass.Prof.
Västra Götalandsregion
QC-verified PI×1
francesca graziani
FPG
QC-verified PI×1
Antonia Camporeale
IRCCS Policlinico S. Donato
QC-verified PI×1
Vincent ESNAULT, PU-PH
CHU NICE
QC-verified PI×1
Monica A Lopez Rodriguez
Hospital Universitario Ramon y Cajal
QC-verified PI×1
Pierre-Alexandre Krayenbühl
Spital Linth
QC-verified PI×1
Xiaoping Ji
Qilu Hospital of Shandong University
QC-verified PI×2
Chet Whitley
University of Minnesota
QC-verified PI×1
Malte Lenders
Rare Disease / Clinical Research
University Hospital Muenster
4
Camilla Tøndel
Rare Disease / Clinical Research
linical Science
3
Aleš Linhart
Rare Disease / Clinical Research
Charles University
3
Juan Politei
Rare Disease / Clinical Research
Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN)
3
Alberto Ortiz
Rare Disease / Clinical Research
Jiménez Díaz Foundation University Hospital
2
Albina Nowak
Rare Disease / Clinical Research
ndocrinology and Clinical Nutrition
2
Frank Weidemann
Rare Disease / Clinical Research
Academic Teaching Hospital
2
Daniel Franzen
University Hospital Zurich, Divison of Internal Medicine
QC-verified PI×4
Einat Brill Almon
Rare Disease / Clinical Research
Protalix Biotherapeutics
2
Sari Alon
Rare Disease / Clinical Research
Protalix Biotherapeutics
2
John A Bernat, M.D
Rare Disease / Clinical Research
University of Iowa Hospitals and Clinics
BOARDMAN, OH
2
Michele Ciabatti
Rare Disease / Clinical Research
San Donato Hospital
2
Dominique P GERMAIN
Centre de reference de la maladie de Fabry et des maladies hereditaires du tissu conjonctif. Assistance Publique Hopitaux de Paris
QC-verified PI×1
Behzad Najafian, MD
University of Washington Associate Professor, Pathology
SEATTLE, WA
QC-verified PI×1
Christoph Wanner, M.D
Rare Disease / Clinical Research
University Hospital of Würzburg
MORRIS, MN
2
Myrl Holida, PAC
Rare Disease / Clinical Research
University of Iowa Hospitals and Clinics
IOWA CITY, IA
2
Patrick Deegan, PharmD
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2
Rossana Rocco
Rare Disease / Clinical Research
Chiesi Farmaceutici S.p.A.
2
Elisabete Martins
Universidade do Porto
QC-verified PI×2
Inderpal Panesar, MRPharmS
AVROBIO, Inc
QC-verified PI×2
Geu-Ru Hong
Severance Hospital
QC-verified PI×1
Gheona Altresko
QC-verified PI×1
Anette T Moller
Danish Pain Research Center
QC-verified PI×1
Raul Chertkoff
Protalix Ltd.
QC-verified PI×1
Michael West
Queen Elizabeth II Health Sciences Centre, Victoria General Site
QC-verified PI×1
Ulla V Feldt-Rasmussen
Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet
QC-verified PI×1
Richard Steeds
University Hospital Birmingham NHS Foundation Trust
QC-verified PI×1

More about Fabry disease

Disease overview →
Treatments →
Clinical trials →